Narayana Hrudayalaya Ltd (NH) Q2 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

Narayana Hrudayalaya is one of India's largest hospital operators, and its Q2 FY27 print arrives with the consolidated EBITDA margin at 18.8% against management's 'slightly over 22%' normalized guide. The quarter will be the first to reflect the July Cayman insurance repricing and a UK recovery from the Q1 heatwave, set against new wage and power cost pressures in India.

Narayana Hrudayalaya Ltd Q2 Results Date and Time

The board will meet on October 30, 2026, to approve the Q2/H1 FY27 results for the period ended September 30, 2026.

An earnings conference call is scheduled for November 2, 2026, at 3:00 PM IST, with a webcast available.

What to expect from Narayana Hrudayalaya Ltd's Q2 FY27 results

The Q2 FY27 print will test whether the consolidated EBITDA margin, at 18.8% in Q1 FY27, begins closing the 320 bps gap to management's 'slightly over 22%' normalized guide as one-time acquisition costs annualize. Two company-flagged recovery levers sit inside the Q2 cycle: the July Cayman insurance repricing, which drew 100% renewal acceptance and follows the US$(3.7) Mn Q1 insurance loss, and a UK recovery from the heatwave that management called a one-off, with HVAC remediation underway. India enters the quarter on +17.0% YoY revenue momentum with ARPOB at Rs. 19.2 Mn (+9.09% YoY), while the CFO has said India net margin expanded 400 bps YoY even after clinic losses and that the margin trajectory will be upward 'in the medium term'. Cost pressures are building, though: Karnataka's ~60% minimum-wage revision lands on the labour-intensive India cost stack, the EPF wage ceiling rose to Rs. 25,000 effective September 17, 2026, and the rupee's slide to 95.93/USD on September 17, 2026 cuts both ways — a translation tailwind on the Cayman/UK revenue base but a revaluation headwind on the US$115 Mn and £150 Mn FX debt. The call is also likely to cover the South-West Bangalore commissioning guided by end of Q2 FY27, the narrowing path for the Rs. 624.61 Mn India insurance segment loss, and the FY27 consolidated capex guidance promised 'closer to the end of this year'.

Key Things To Watch

Margin bridge toward the ~22% normalized guide: Q1 FY27 printed 18.8% consolidated EBITDA margin, a 320 bps gap to the guided normalized level.

• Normalized consolidated EBITDA margin ~22% (open-ended) — watch whether Q2 shows progression as one-time acquisition costs annualize
• Margin trajectory upward 'in the medium term' — test whether Q2 EBITDA margin inflects from 18.8%
• Group overheads 28% → 23% (open-ended) — track UK integration overhead synergies

Cayman insurance recovery after July repricing: July repricing with 100% renewal acceptance kicks into the Q2 cycle.

• Cayman insurance EBITDA path from US$(3.7) Mn in Q1 FY27 — management expects improved financial performance in Q2, barring abnormal large-claim swings
• Loss ratio versus the ~110–112% flagged when Q4 FY26 losses of USD 5 Mn overshot the prior breakeven-by-Q1 FY27 expectation
• India insurance drag 'a couple more quarters' — check whether the Rs. (624.61) Mn Q1 segment loss narrows

UK post-heatwave recovery and integration: Q1 UK losses rose on a heatwave that management called a one-off.

• UK recovery and HVAC remediation progress after the heatwave caused loss of operating capacity in Q1 FY27
• UK EBITDA margin versus the 10.5% posted in Q4 FY26
• UK NHS dependence 95% → ~70% over 4-5 years — private contribution at an all-time high but low versus peers

Capex, commissioning and guidance tracking: India capex of ~Rs. 3,000 crores over three years with commissioning FY28-'29.

• South-West Bangalore start by end of Q2 FY27 — confirm commissioning status
• FY27 capex guidance promised 'closer to the end of this year' — check if it is provided
• Net Debt/EBITDA below 2.5x (open-ended) — 0.97x on annualized Q1 FY27 EBITDA; net debt already reduced by Rs. 2,726 Mn QoQ to Rs. 19,671 Mn

New asset-light additions and reporting changes: Two asset-light bed additions were announced October 5, 2026.

• First revenue contribution commentary from KS-Narayana Bengaluru (110 beds, commissioned Oct 5, 2026) and the 100-bed Kolkata O&M agreement with Mission of Mercy Hospital
• Clinic business now reported within hospitals from FY27 — watch comparability; insurance continues to be reported separately
• NCLT status on the MMRHL merger and NHIC demerger; UK capex plan still to be shared